Literature DB >> 19935593

Quality of life and patients' view of compression therapy.

S Reich-Schupke1, F Murmann, P Altmeyer, M Stücker.   

Abstract

AIM: Although compression therapy is the corner stone of phlebological therapy, less is known about the patients' view of compression. The aim of the study was to answer the following questions: Are there differences in the use of compression and the quality of life during compression therapy depending on the device (bandages, stocking [medical compression stockings, MCS], length, compression class) or indication of compression?
METHODS: Questioning of 200 consecutive phlebological patients (C2-C6) with a compression therapy time of >2 weeks. Analysis of 110 returned questionnaires (rate of return 55%).
RESULTS: Twenty-nine point one percent voted the therapy as "comfortable". About 37% of the patients had an improvement of their leg symptoms by using compression therapy. Most patients (105/110) wore their compression therapy for more than 6 hours/day. The main side effects were dryness of the skin (58.5%), itching (32.7%), slipping (29.1%) or constriction of the compression device (24.5%). There were no significant differences in the side effect spectrum or the usage according to the type of compression device or the indication for the treatment (varicose surgery/ sclerotherapy). Patients with a leg ulcer and longer duration of compression therapy experienced a worse quality of life.
CONCLUSIONS: Patients accept the recommended compression therapy (alone or in combination with other phlebological therapies) as a necessary therapy. Compression devices are really used by the patients. According to the main side effect (dryness of the skin), improvement is essential (skin care, caring MCS). Especially patients with indication for a long-term or even life-long compression therapy should be advised in detail.

Entities:  

Mesh:

Year:  2009        PMID: 19935593

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  9 in total

1.  [Quality of self-applied compression bandages in patients with chronic venous ulcers : Results of a prospective clinical study].

Authors:  M Stoffels-Weindorf; I Stoffels; F Jockenhöfer; J Dissemond
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

Review 2.  [Innovations in medical compression therapy].

Authors:  H Riebe; W Konschake; T Westphal; M Jünger
Journal:  Hautarzt       Date:  2020-01       Impact factor: 0.751

3.  [Which patients follow the physician's recommendation to take edema-protective agents? : A retrospective, descriptive study].

Authors:  M Stücker; B Larenz
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

4.  The impact of skin grafting on the quality of life and self-esteem of patients with venous leg ulcers.

Authors:  Geraldo M Salomé; Leila Blanes; Lydia M Ferreira
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

5.  Impact of skin grafting of venous leg ulcers on functional status and pain.

Authors:  Geraldo Magela Salomé; Lydia M Ferreira
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

6.  Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

7.  Reasons for patient non-compliance with compression stockings as a treatment for varicose veins in the lower limbs: A qualitative study.

Authors:  Jian-Mei Gong; Jian-Shi Du; Dong-Mei Han; Xin-Yu Wang; Shao-Long Qi
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

8.  The effect of wearing insoles with a toe-grip bar on occupational leg swelling and lower limb muscle activity: A randomized cross-over study.

Authors:  Hideki Nakano; Shin Murata; Yoshihiro Kai; Teppei Abiko; Dai Matsuo; Michio Kawaguchi
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

9.  The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study.

Authors:  Andrzej Berszakiewicz; Janusz Kasperczyk; Aleksander Sieroń; Zbigniew Krasiński; Armand Cholewka; Agata Stanek
Journal:  Postepy Dermatol Alergol       Date:  2020-01-31       Impact factor: 1.837

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.